CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +958 | $1.03 | $982 | 958 |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +143,275 | $1.03 | $148K | 144,233 |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +19,358 | $1.04 | $20K | 163,591 |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +30,642 | $1.04 | $32K | 194,233 |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +12,700 | $1.05 | $13K | 206,933 |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +25,845 | $1.06 | $27K | 233,778 |
| 2023-08-16 | Holt Patrick President and CEO | Purchase | +67,222 | $1.06 | $71K | 300,000 |
| 2023-08-01 | Holt Patrick President and CEO | Grant or award · Stock Option (Right to Buy) | +5,000,000 | 5,000,000 | ||
| 2023-07-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Unit | +23,883 | 0 | ||
| 2023-07-31 | Berg Aaron President and CEO | Option exercise · Restricted Stock Unit | +23,883 | 0 | ||
| 2023-07-31 | Berg Aaron EVP, President US | Option exercise | +23,883 | 545,145 | ||
| 2023-07-31 | Berg Aaron EVP, President US | Shares withheld for taxes | −11,763 | $1.19 | $14K | 533,382 |
| 2023-07-31 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Unit | +23,883 | 23,883 | ||
| 2023-07-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +23,883 | 611,994 | ||
| 2023-07-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −11,763 | $1.19 | $14K | 600,231 |
| 2023-07-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Unit | +23,883 | 23,883 | ||
| 2023-07-21 | Odysseas Kostas D Director | Grant or award · Stock Option (Right to Buy) | +258,598 | 284,598 | ||
| 2023-07-21 | Odysseas Kostas D Director | Grant or award · Stock Option (Right to Buy) | +180,804 | 180,804 | ||
| 2023-07-21 | Odysseas Kostas D Director | Grant or award · Restricted Stock Units | +94,866 | 94,866 | ||
| 2023-07-21 | Odysseas Kostas D Director | Grant or award · Restricted Stock Units | +60,268 | 60,268 |
Page 13 of 67 · 1,339 trades